Anti-RSPH3 monoclonal antibody

Pre-made anti-RSPH3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RSPH3/RSPH3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2720-Ab-1/ GM-Tg-hg-IP2720-Ab-2Anti-Human RSPH3 monoclonal antibodyHuman
GM-Tg-rg-IP2720-Ab-1/ GM-Tg-rg-IP2720-Ab-2Anti-Rat RSPH3 monoclonal antibodyRat
GM-Tg-mg-IP2720-Ab-1/ GM-Tg-mg-IP2720-Ab-2Anti-Mouse RSPH3 monoclonal antibodyMouse
GM-Tg-cynog-IP2720-Ab-1/ GM-Tg-cynog-IP2720-Ab-2Anti-Cynomolgus/ Rhesus macaque RSPH3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2720-Ab-1/ GM-Tg-felg-IP2720-Ab-2Anti-Feline RSPH3 monoclonal antibodyFeline
GM-Tg-cang-IP2720-Ab-1/ GM-Tg-cang-IP2720-Ab-2Anti-Canine RSPH3 monoclonal antibodyCanine
GM-Tg-bovg-IP2720-Ab-1/ GM-Tg-bovg-IP2720-Ab-2Anti-Bovine RSPH3 monoclonal antibodyBovine
GM-Tg-equg-IP2720-Ab-1/ GM-Tg-equg-IP2720-Ab-2Anti-Equine RSPH3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2720-Ab-1/ GM-Tg-hg-IP2720-Ab-2; GM-Tg-rg-IP2720-Ab-1/ GM-Tg-rg-IP2720-Ab-2;
GM-Tg-mg-IP2720-Ab-1/ GM-Tg-mg-IP2720-Ab-2; GM-Tg-cynog-IP2720-Ab-1/ GM-Tg-cynog-IP2720-Ab-2;
GM-Tg-felg-IP2720-Ab-1/ GM-Tg-felg-IP2720-Ab-2; GM-Tg-cang-IP2720-Ab-1/ GM-Tg-cang-IP2720-Ab-2;
GM-Tg-bovg-IP2720-Ab-1/ GM-Tg-bovg-IP2720-Ab-2; GM-Tg-equg-IP2720-Ab-1/ GM-Tg-equg-IP2720-Ab-2
Products NameAnti-RSPH3 monoclonal antibody
Formatmab
Target NameRSPH3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RSPH3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2720-Ag-1Recombinant multi-species RSPH3/ CILD32/ RSHL2 protein


    Target information

    Target IDGM-IP2720
    Target NameRSPH3
    Gene ID83861,361476,114669855,484057,101096480,533135,100059353
    Gene Symbol and SynonymsCILD32,dJ111C20.1,RSHL2,RSP3,RSPH3
    Uniprot AccessionQ86UC2,A8E4N3
    Uniprot Entry NameRSPH3_HUMAN,RSPH3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130363
    Target ClassificationN/A

    The target: RSPH3, gene name: RSPH3, also named as CILD32, RSHL2, RSP3, dJ111C20.1. The protein encoded by this gene acts as a protein kinase A anchoring protein. Mutations in this gene cause primary ciliary dyskinesia; a disorder characterized by defects of the axoneme in motile cilia and sperm flagella. The homolog of this gene was first identified in the blue-green algae Chlamydomonas as encoding a radial spoke protein that formed a structural component of motile cilia and flagella. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.